Chair, Programs Committee
Steve R. Martin
Steve R. Martin is an experienced Chief Financial Officer for publicly-held reporting companies. He has managed all aspects of investor relations, financing activities and Board of Director matters, and has extensive mergers and acquisitions experience.
Currently, he serves as Senior Vice President and Chief Financial officer of Armata Pharmaceuticals, Inc., a publicly-traded biotechnology company pioneering the development and commercialization of therapies for antibiotic-resistant infections using bacteriophage-based technology. In 2019, Armata was formed by the merger of AmpliPhi Biosciences and C3J Therapeutics in a stock-for-stock transaction.
In April 2018, he was appointed to Board of Directors of Dthera Sciences, a publicly-traded, digital therapeutics company, where he serves as Chairman on the Audit Committee.
Prior to his current position, Steve served as Senior Vice President and Chief Financial Officer at Apricus Biosciences, Inc. and BakBone Software Incorporated. He also served as Interim CEO at both organizations. At BakBone Software Incorporated, he lead the Board of Directors, investment bankers and executive team through a 7-month strategic sale process, leading to the eventual sale of the Company to Quest Software, an all cash $56M transaction.